NASDAQ: VXRT       Vaxart Inc
Last Price Today's Change   Day's Range   Trading Volume
0.307   -0.013 (4.06%)  0.301 - 0.32  48,792


Avg Volume (4 weeks):569,484
4 Weeks Range:0.266 - 0.419
4 Weeks Price Volatility (%):
52 Weeks Range:0.25 - 5.00
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Vaxart Inc, formerly known as Aviragen Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics; BTA585, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus. Geographically all the business activity is functioned through the region of US.

  Be the first to like this.


2267  3325  459  2916 

Top 10 Active Counters
 CELG 108.24+0.11 
 AMD 41.581-1.009 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 CHK 0.796+0.013 
 GE 11.394-0.046 
 BBT 54.24+0.75 
 CBS 40.77+1.43 
 BAC 34.432-0.248 
 NIO 2.395+0.125 
Partners & Brokers